Pharmaniaga Berhad

Informe acción KLSE:PHARMA

Capitalización de mercado: RM 511.6m

Pharmaniaga Berhad Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Zulkifli Bin Jafar

Chief Executive Officer (CEO)

RM 168.6k

Compensación total

Porcentaje del salario del CEO83.1%
Permanencia del CEOless than a year
Participación del CEOn/a
Permanencia media de la dirección1.3yrs
Promedio de permanencia en la Junta Directiva2.5yrs

Actualizaciones recientes de la dirección

Recent updates

Pharmaniaga Berhad's (KLSE:PHARMA) Shares Bounce 25% But Its Business Still Trails The Industry

Jul 18
Pharmaniaga Berhad's (KLSE:PHARMA) Shares Bounce 25% But Its Business Still Trails The Industry

Why Investors Shouldn't Be Surprised By Pharmaniaga Berhad's (KLSE:PHARMA) Low P/S

May 09
Why Investors Shouldn't Be Surprised By Pharmaniaga Berhad's (KLSE:PHARMA) Low P/S

Pharmaniaga Berhad (KLSE:PHARMA) Shares Could Be 49% Below Their Intrinsic Value Estimate

Apr 19
Pharmaniaga Berhad (KLSE:PHARMA) Shares Could Be 49% Below Their Intrinsic Value Estimate

Insufficient Growth At Pharmaniaga Berhad (KLSE:PHARMA) Hampers Share Price

Oct 03
Insufficient Growth At Pharmaniaga Berhad (KLSE:PHARMA) Hampers Share Price

Is There An Opportunity With Pharmaniaga Berhad's (KLSE:PHARMA) 37% Undervaluation?

Jul 19
Is There An Opportunity With Pharmaniaga Berhad's (KLSE:PHARMA) 37% Undervaluation?

Is It Too Late To Consider Buying Pharmaniaga Berhad (KLSE:PHARMA)?

Feb 18
Is It Too Late To Consider Buying Pharmaniaga Berhad (KLSE:PHARMA)?

Many Would Be Envious Of Pharmaniaga Berhad's (KLSE:PHARMA) Excellent Returns On Capital

Dec 10
Many Would Be Envious Of Pharmaniaga Berhad's (KLSE:PHARMA) Excellent Returns On Capital

Bullish: Analysts Just Made A Massive Upgrade To Their Pharmaniaga Berhad (KLSE:PHARMA) Forecasts

Nov 24
Bullish: Analysts Just Made A Massive Upgrade To Their Pharmaniaga Berhad (KLSE:PHARMA) Forecasts

We Think That There Are Issues Underlying Pharmaniaga Berhad's (KLSE:PHARMA) Earnings

Aug 27
We Think That There Are Issues Underlying Pharmaniaga Berhad's (KLSE:PHARMA) Earnings

Pharmaniaga Berhad (KLSE:PHARMA) Has A Somewhat Strained Balance Sheet

May 28
Pharmaniaga Berhad (KLSE:PHARMA) Has A Somewhat Strained Balance Sheet

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Zulkifli Bin Jafar en comparación con los beneficios de Pharmaniaga Berhad?
FechaCompensación totalSalarioIngresos de la empresa
Jun 30 2024n/an/a

-RM 56m

Mar 31 2024n/an/a

-RM 57m

Dec 31 2023RM 169kRM 140k

-RM 80m

Sep 30 2023n/an/a

-RM 667m

Jun 30 2023n/an/a

-RM 654m

Mar 31 2023n/an/a

-RM 655m

Dec 31 2022RM 1mRM 800k

-RM 630m

Sep 30 2022n/an/a

RM 100m

Jun 30 2022n/an/a

RM 164m

Mar 31 2022n/an/a

RM 177m

Dec 31 2021RM 145kn/a

RM 172m

Sep 30 2021n/an/a

RM 80m

Jun 30 2021n/an/a

RM 32m

Mar 31 2021n/an/a

RM 28m

Dec 31 2020RM 61kn/a

RM 27m

Compensación vs. Mercado: La compensación total de Zulkifli($USD37.85K) está por debajo de la media de empresas de tamaño similar en el mercado MY ($USD108.01K).

Compensación vs. Ingresos: La compensación de Zulkifli ha sido consistente con los resultados de la empresa en el último año.

CEO

Zulkifli Bin Jafar (52 yo)

less than a year

Permanencia

RM 168,569

Compensación

Encik Zulkifli Bin Jafar is the Managing Director at Pharmaniaga Berhad since September 1, 2024 and serves as its Deputy Chief Executive Officer since February 22, 2023 and was its Executive Director since...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Zulkifli Bin Jafar
Deputy CEO & Managing Directorless than a yearRM 168.57ksin datos
Norai'ni Binti Mohamed Ali
Chief Financial Officer12.4yrssin datossin datos
Ahmad Shahredzuan Mohd Shariff
COO & Directorless than a yearRM 136.05ksin datos
Badarulhisam Rahman
Chief Scientific Officer1.8yrssin datossin datos
Abdul Mohamed
Executive Vice President of Logistics & Distribution Divisionno datasin datossin datos
Zulhazri bin Razali
Executive Vice President of Commercial Divisionno datasin datossin datos
Wan Intan Wan Ismail
Executive VP of Corporate Governance & Company Secretary5yrssin datossin datos
Azni Basri
Chief People Officerless than a yearsin datossin datos
Idham Ismail
Chief Strategy Officerno datasin datossin datos
Mohd Ishak
Acting Head of Manufacturing Operationsless than a yearsin datossin datos
Fazleena Jasin
Head of Sustainabilityno datasin datossin datos
Syaruzaimi Yusof
Company Secretary5yrssin datossin datos

1.3yrs

Permanencia media

54yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de PHARMA no se considera experimentado ( 1.3 años antigüedad media), lo que sugiere un nuevo equipo.

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Zulkifli Bin Jafar
Deputy CEO & Managing Directorless than a yearRM 168.57ksin datos
Ahmad Shahredzuan Mohd Shariff
COO & Director1.8yrsRM 136.05ksin datos
Ahmad Bakar
President Director of PT Millennium Pharmacon International Tbk4.3yrssin datossin datos
Yves Champey
Member of Board Advisory Panelno datasin datossin datos
Izaddeen Bin Daud
Non-Independent Director3.7yrsRM 192.81ksin datos
Mohd Bin Zahur Hussain
Independent Non Executive Directorless than a yearRM 40.00ksin datos
V. Navaratnam
Member of Board Advisory Panelno datasin datossin datos
Musa bin Mohamad
Chairman of Board Advisory Panelno datasin datossin datos
Piero Olliaro
Member of Board Advisory Panelno datasin datossin datos
Sarah binti Abdul Samat
Independent & Non-Executive Director3.3yrsRM 181.67ksin datos
Abdul Bin Jaafar
Independent Non Executive Chairmanless than a yearsin datossin datos
Abdul Bin Ahmad
Senior Independent & Non-Executive Director4yrsRM 190.04ksin datos

2.5yrs

Permanencia media

52yo

Promedio de edad

Junta con experiencia: La junta directiva de PHARMA no se considera experimentada (2.5 años de permanencia promedio), lo que sugiere una nueva junta directiva.